Opthamologist News


Welcome to the Opthamologist News page (Ophthalmologist News ).

This page is intended as a quick update on whats going on in the world of Opthamology, including ophthalmology studies, news and general articles. Have a browse and see if something catches your eye.

We have also added another  Opthalmology news page, that includes only the latest medical studies and results, so if you are an Opthamologist, then it is also worth a read: Ophthalmology Journal.

For our ‘General Eye Health’ news page, please see: Eye Health.

Enjoy reading.

Opthamologist News:

DEMENTIA symptoms commonly include memory loss and difficulty making decisions, but could an eye test help spot the condition early? (Source: Daily Express - Health)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Posted: November 23, 2017, 3:01 am
We present high-resolution structures of ChR2 and the C128T mutant, which has a markedly increased open-state lifetime. The structure reveals two cavities on the intracellular side and two cavities on the extracellular side. They are connected by extended hydrogen-bonding networks involving water molecules and side-chain residues. Central is the retinal Schiff base that controls and synchronizes three gates that separate the cavities. Separate from this network is the DC gate that comprises a water-mediated bond between C128 and D156 and interacts directly with the retinal Schiff base. Comparison with the C128T structure reveals a direct connection of the DC gate to the central gate and suggests how the gating mechanism is affected by subtle tuning of the Schiff base’s interactions. ...
Posted: November 22, 2017, 11:00 pm
(Source: ScienceNOW)
Posted: November 22, 2017, 11:00 pm
The FDA has cleared RxSight‘s implantable light adjustable intraocular lens and light delivery device. The company’s RxSight IOL is designed from a UV light reactive material meant to be treated by a specific Light Delivery Device, intended for use 17 to 21 days post-procedure. The lens is designed to be treated by 3-4 light treatments over 1 to 2 weeks in 40 to 150 second treatment periods, during which the patient must wear UV-protective glasses. “Until now, refractive errors that are common following cataract surgery could only be corrected with glasses, contact lenses or refractive surgery. This system provides a new option for certain patients that allows the physician to make small adjustments to the implanted lens during several in-office procedures after the initi...
Posted: November 22, 2017, 6:46 pm
This article reviews the efficacy of several minimally invasive browpexy techniques to address brow ptosis. How do they measure up?Current Opinion in Ophthalmology (Source: Medscape Today Headlines)
Posted: November 22, 2017, 4:14 am
A proposed class of Restasis buyers filed an antitrust suit last week in a Texas federal court against Allergan (NYSE:AGN), according to reports from Law360. The suit accuses Allergan of blocking generics to its dry-eye drug using tactics like sham infringement suits and a controversial deal with a Native American tribe. Get the full story at our sister site, Drug Delivery Business News. The post Restasis buyers level antitrust lawsuit against Allergan appeared first on MassDevice. (Source: Mass Device)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Posted: November 21, 2017, 8:26 pm
The FDA last week approved remote programming adjustments for Cochlear Ltd.‘s (ASX:COH) Nucleus cochlear implant, removing the need for a select group of users  to make repeat visits for in-person programming sessions. The newly-cleared remote programming feature is indicated for patients with 6 months of experience with their cochlear implant sound processors and who are comfortable with the programming process, according to an FDA release. Normally, such implants would require regular programming visits with an audiologist in which electronic settings that control how the implant stimulates nerves in the ear are adjusted. This can include changes to sensitivity to low-level sound and limits on loud sounds, according to the release, and affect how patients perceive different sounds...
Posted: November 21, 2017, 4:16 pm
Cambridge Consultants showed off its prototype of a miniaturized robot designed for cataract surgery last week at its annual Innovation Day event. The system, Axsis, is one of the smallest known robots for surgical use, according to the firm, featuring instruments of just 1.8mm in diameter. Get the full story at our sister site, The Robot Report. The post Cambridge Consultants prototypes miniaturized robot for cataract surgery appeared first on MassDevice. (Source: Mass Device)
Posted: November 20, 2017, 6:16 pm
Eight - item tool developed for clinicians to identify trustworthy, useful, and relevant guidelines (Source: The Doctors Lounge - Oncology)
Posted: November 18, 2017, 12:00 am
A screening program in Baltimore that used autorefraction to assess patients ’ eyesight, and then provided free eyeglasses to them, yielded a high level of satisfaction, according to a new report.Reuters Health Information (Source: Medscape Medical News Headlines)
Posted: November 17, 2017, 8:42 pm
Eye care is one of the most common acute medical needs after natural disasters, and having a plan in place speeds aid.Medscape Medical News (Source: Medscape Medical News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Posted: November 17, 2017, 6:34 pm
New result bodes well for next-generation optoelectronics instruments, such as tunable infrared detectors, light-emitting diodes and lasers. (Source: Nanotechweb.org News)
Posted: November 17, 2017, 5:55 pm
Findings in case study of man being treated for non - small - cell lung cancer (Source: The Doctors Lounge - Oncology)
Posted: November 17, 2017, 5:00 pm
Staar Surgical (NSDQ:STAA) this week reported results from the feasibility clinical study of its Evo+ Visian ICL with aspheric optics designed to reduce presbyopia, and that based on the results it plans to launch a pivotal clinical study of the device during the 1st quarter next year. The Monrovia, Calif.-based company’s EVO+ Visian ICL is designed to be surgically implanted and operate with the patient’s eye to correct vision. The lens is designed to be positioned inside the eye between the iris and natural lens where it stays indefinitely. Staar Surgical said that it presented results from 24 patients involved in the feasibility study on its investor and analyst day yesterday, according to an SEC filing. In August, Staar Surgical saw shares rise slightly after the medical device ma...
Posted: November 17, 2017, 4:00 pm
Implandata Ophthalmic Products today touted the first-in-human use of its next-gen Eyemate micro-sensor implant designed to monitor intraocular pressure. The Eyemate microsensor is designed for the continuous monitoring of intraocular pressure and can be checked remotely, removing the need for a patient to visit a doctor’s office for measurements, the Hannover, Germany-based company said. “This opens up the path to proceed forward towards design finalization, expanded clinical validation and regulatory approval. Eventually this will further increase the use of the Eyemate system,” CEO Max Ostermeier said in a prepared statement. Implandata touted that the next-gen Eyemate system also reduces incision size for implantation down to 2.7 mm from 4 mm. The system includes the...
Posted: November 17, 2017, 2:58 pm
iVeena Delivery Systems said earlier this month that it finished a pilot trial for its IVMED-10 bioerodible implant designed to treat pain and inflammation after cataract surgery. Placed during cataract surgery, the sustained-release implant delivers dexamethasone for two weeks from the lens capsule. Get the full story at our sister site, Drug Delivery Business News. The post iVeena finishes pilot trial of sustained-release implant appeared first on MassDevice. (Source: Mass Device)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Posted: November 17, 2017, 2:15 pm
(Source: RxList - New and Updated Drug Monographs)
Posted: November 17, 2017, 6:00 am
Baby Boomers appear less likely than their predecessors to develop macular degeneration, according to a study in JAMA Ophthalmology. Researchers examined nearly 5000 adults in... (Source: Physician's First Watch current issue)
Posted: November 17, 2017, 2:17 am
Retinal pigment epithelial cells derived from human embryonic stem cells can be safely transplanted into the eyes of patients with retinal degeneration, with early signs of vision gain.Medscape Medical News (Source: Medscape Medical News Headlines)
Posted: November 17, 2017, 12:11 am
Descemet membrane endothelial keratoplasty provides better outcomes than Descemet-stripping in patients requiring cornea transplant who have already had glaucoma surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Posted: November 16, 2017, 7:28 pm

-Please browse our other news pages, and find opthamologists and optometrists in your area. See the navigation.


Leave a Reply

Your email address will not be published. Required fields are marked *